Nitric oxide in pulmonary arteriovenous malformations and Fontan procedure.
暂无分享，去创建一个
[1] H. Ashrafian,et al. The mechanism of formation of pulmonary arteriovenous malformations associated with the classic Glenn shunt (superior cavopulmonary anastomosis) , 2002, Heart.
[2] H. Gombotz,et al. Successful management of severe life-threatening hypoxemia due to pulmonary arteriovenous malformation. , 2002, Anesthesiology.
[3] E. Chi,et al. A detailed histologic analysis of pulmonary arteriovenous malformations in children with cyanotic congenital heart disease. , 1999, The Journal of thoracic and cardiovascular surgery.
[4] M. Fogel,et al. Pulmonary AV malformations after superior cavopulmonary connection: resolution after inclusion of hepatic veins in the pulmonary circulation. , 1997, The Annals of thoracic surgery.
[5] B. Rigler,et al. Inhaled nitric oxide in patients with critical pulmonary perfusion after Fontan-type procedures and bidirectional Glenn anastomosis. , 1997, The Journal of thoracic and cardiovascular surgery.
[6] N. Silverman,et al. Development of pulmonary arteriovenous fistulae in children after cavopulmonary shunt. , 1995, Circulation.
[7] R. Mee,et al. A cure for pulmonary arteriovenous fistulas? , 1995, The Annals of thoracic surgery.
[8] E. Bacha,et al. Management of pulmonary arteriovenous malformations after surgery for complex congenital heart disease. , 2000, The Journal of thoracic and cardiovascular surgery.